Publications
Here you will find the latest scientific publications related to the studies and research conducted by Santé publique France.
209 publications
article
2009 Vaccination Schedule and Recommendations, as recommended by the High Council for Public Health
article
Women Who Use Drugs and Practices Associated with the Risk of HIV and Hepatitis Transmission: Complementary Epidemiological and Socio-Anthropological Approaches, Coquelicot Survey 2004–2007, France
rapport/synthèse
Surveillance of Blood-Exposure Incidents in French Healthcare Facilities in 2006 - Results
article
2007 Vaccination Schedule and recommendations issued since the 2006 Vaccination Schedule
article
List of opinions issued by the French High Council for Public Health (Communicable Diseases Section) regarding vaccination, published since the 2000 vaccination schedule
article
Opinion of the French High Council for Public Health (Committee on Communicable Diseases) regarding hepatitis A vaccination in patients with chronic hepatitis B infection, June 21, 2002
article
2003 Vaccination Schedule. Opinion of the French High Council for Public Health, January 17, 2003
article
Surveillance of markers for HIV, HTLV, and hepatitis B and C virus infection among blood donors in France from 1991 to 2000
article
HIV, HCV, and HBV Infections Among Residents of Residential Treatment Centers for Substance Users, 1993–1998
article
Opinion of the French High Council for Public Health on vaccination against viral hepatitis B
In relation to
Hepatitis C
thematic dossier
Hepatitis C is a viral infection primarily transmitted through blood. Screening for the disease is crucial to ensuring that infected individuals receive the treatments that can now lead to a cure.
HIV/AIDS
thematic dossier
HIV, or Human Immunodeficiency Virus, is a sexually transmitted human retrovirus. It weakens the immune system, and if left untreated, leads to AIDS.
Vaccination
thematic dossier
Contagious diseases most often affect children at a very young age. Because children are particularly vulnerable, they are a priority target for vaccination programs.
